市場調查報告書
商品編碼
1535230
氣球鼻竇形成術系統市場:各市場區隔規模,佔有率,法律規章,償付,手術,2033年為止的預測Balloon Sinuplasty Systems Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
球囊鼻竇成形術系統,也稱為球囊擴張導管系統或鼻竇擴張系統,是一種利用球囊導管和充氣裝置來打開阻塞的鼻竇通道的裝置。
慢性鼻竇炎 (CRS) 是一種持續超過 12 週的鼻竇和鼻腔發炎性疾病。慢性鼻竇炎是一組具有共同臨床和病理特徵的異質性疾病。球囊鼻竇成形術正迅速成為慢性或嚴重鼻竇炎的首選手術,這些鼻竇炎對其他藥物治療(如鼻減充血劑和沖洗劑、抗生素以及鼻和口服皮質類固醇)沒有反應,並且已被廣泛應用。
本報告提供全球氣球鼻竇形成術系統市場相關資料詳細考察,提供市場上競爭情形,SWOT分析,到2033年為止的市場預測,地區,各國的趨勢等資訊。
Balloon Sinuplasty Systems Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within ENT Devices therapeutic area.
Balloon sinuplasty systems, also known as balloon dilation catheter systems or sinus dilation systems, are devices which are used to open blocked sinus passages using balloon catheters & inflation devices.
Chronic rhinosinusitis (CRS) is an inflammatory disorder of paranasal sinuses and lining of the nasal passages that lasts 12 weeks or longer. It is a heterogenous group of disorders that share certain clinical and pathologic features. Balloon sinuplasty is quickly becoming the surgery of choice for chronic or severe sinusitis that does not respond to other medical therapies, such as nasal decongestant medications and rinses, antibiotics, and nasal and oral corticosteroids.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Balloon Sinuplasty Systems and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Acclarent Inc, Medtronic Plc, Entellus Medical Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -